MARINA MILLER: Open Payments
NPI 1932884707 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 17 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $204 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Verona Pharma, Inc. | 3 | $58 |
| Exact Sciences Corporation | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| PFIZER INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| TMS NeuroHealth Centers Inc. | 1 | $15 |
Products named: VRAYLAR, Auvelity, Ohtuvayre, Cologuard Collection Kit, Kerendia, AIRSUPRA, PREVNAR 20, MOUNJARO.
Industry payments across MD — which companies pay providers there.
